Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-22

Clinical Trial Update: Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial examining emergency department-initiated extended-release naltrexone with case management for alcohol use disorder was terminated; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • extended-release naltrexone (naltrexone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Alcohol Use Disorder, Substance Use | Phase 4 | Status: TERMINATED | Results posted: 2023-06-22